1. Guest, the 'News in Brief' for the week beginning 11th January 2021 is here.
    Dismiss Notice
  2. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Ampligen - Hemispherx Biopharma re ME/CFS

Discussion in 'BioMedical ME/CFS News' started by Sly Saint, Nov 24, 2017.

  1. Sly Saint

    Sly Saint Senior Member (Voting Rights)

    Messages:
    5,567
    Likes Received:
    45,904
    Location:
    UK
  2. Sly Saint

    Sly Saint Senior Member (Voting Rights)

    Messages:
    5,567
    Likes Received:
    45,904
    Location:
    UK
    not relating to ME but Covid-19
    AIM ImmunoTech inks deal to research vaping device as a vehicle for Ampligen to treat coronavirus
    https://www.proactiveinvestors.com/...for-ampligen-to-treat-coronavirus-916966.html
     
    sebaaa, Kitty, ScottTriGuy and 3 others like this.
  3. Sly Saint

    Sly Saint Senior Member (Voting Rights)

    Messages:
    5,567
    Likes Received:
    45,904
    Location:
    UK
    AIM ImmunoTech Files Provisional Patent Application for the Use of Ampligen(R) as a Potential Therapy for COVID-19 Induced Chronic Fatigue

    https://www.morningstar.com/news/ac...-therapy-for-covid-19-induced-chronic-fatigue
     
    MEMarge and Kitty like this.
  4. sjJohnny

    sjJohnny Established Member (Voting Rights)

    Messages:
    28
    Likes Received:
    107
    You'll find this interesting - especially for those who were not around for the AdCom meetings of 2012-13. Maybe it can be used to petition the FDA.

    "Never mind that Hemispherx had demonstrated that the log transformation data was not warranted or that non transformed data was appropriate …the FDA was mostly interested in whether the biostatistician had ‘followed the rules’. It was a bizarre thing as a patient to watch a drug that could help ill people be held up on procedural issues but there it was."

    https://onbiostatistics.blogspot.com/2020/01/pre-specifications-of-statistical.html
     
    Alton, MEMarge and wigglethemouse like this.
  5. sjJohnny

    sjJohnny Established Member (Voting Rights)

    Messages:
    28
    Likes Received:
    107
    And a recent PR related to Ampligen and CFS/ME.

    AIM ImmunoTech Provides Update on Commercial Launch of Ampligen(R) in Argentina for the Treatment of Chronic Fatigue Syndrome

    Receives clearance from Argentina's FDA to import first shipment of Ampligen® for commercial sale in Argentina

    AIM 'sets sights' on treating COVID-19 induced chronic fatigue in Argentina

    https://aimimmuno.irpass.com/ViewEmail.asp?b=2265&id=190760&p=2176912&I=1201116-E6Z6D3a5b9
     
    sebaaa and Leila like this.
  6. John Mac

    John Mac Senior Member (Voting Rights)

    Messages:
    384
    Likes Received:
    4,656
    AIM ImmunoTech Announces IRB Approval to Enroll COVID-19 ‘Long Haulers’ in the AMP-511 ME/CFS Clinical Trial of Ampligen COVID-19 Patients May Continue to Experience Chronic Fatigue-Like Symptoms

    https://www.biospace.com/article/re...-to-experience-chronic-fatigue-like-symptoms/
     
    Last edited: Oct 13, 2020
    MEMarge, Sly Saint, Michelle and 5 others like this.
  7. Sly Saint

    Sly Saint Senior Member (Voting Rights)

    Messages:
    5,567
    Likes Received:
    45,904
    Location:
    UK
    AIM Trial Moves Ahead, And Other News: The Good, Bad And Ugly Of Biopharma
    https://seekingalpha.com/article/43...ahead-and-news-good-bad-and-ugly-of-biopharma
     

Share This Page